The non-canonical target PARP16 contributes to polypharmacology of the PARP inhibitor talazoparib and its synergy with WEE1 inhibitors - Concepedia

Concepedia

Publication | Open Access

The non-canonical target PARP16 contributes to polypharmacology of the PARP inhibitor talazoparib and its synergy with WEE1 inhibitors

DOI Full Paper Access

37

Citations

47

References

2021

Year

Vinayak Palve, Claire E. Knezevic, Daniel S. Bejan, Yunting Luo, Xueli Li, Silvia Novakova, Eric A. Welsh, Bin Fang, Fumi Kinose, Eric B. Haura,

Cell chemical biology

Medicinal ChemistryDrug TargetMedicineNatural SciencesMechanism Of ActionMolecular BiologyWee1 InhibitorsNon-canonical Target Parp16PharmacotherapyParp Inhibitor TalazoparibPharmacologyDrug Discovery

References

	Year	Citations

Page 1

Page 1